Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Abstract Background Here, the perspective of patients with primary and secondary immunodeficiency receiving subcutaneous immunoglobulin (SCIg) via introductory smaller size pre-filled syringes (PFS) or vials were compared. Methods An online survey was conducted in Canada by the Association des Patie...

Full description

Bibliographic Details
Main Authors: R. Mallick, G. Solomon, P. Bassett, X. Zhang, P. Patel, O. Lepeshkina
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Immunology
Subjects:
Immunodeficiency
Subcutaneous immunoglobulin (SCIg)
Packaging method
Patient reported outcomes
Pre-filled syringes (PFS)
Manual push
Online Access:https://doi.org/10.1186/s12865-024-00608-0

Internet

https://doi.org/10.1186/s12865-024-00608-0

Similar Items